RecruitingNot ApplicableNCT06730555

Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

Project ACCESS: Advancing Access to HIV/HCV Testing Through Transformation in Syringe Services Programs: A Cluster Randomized Trial

Sponsor

University of Miami

Enrollment

40 participants

Start Date

Jun 27, 2025

Study Type

INTERVENTIONAL

Conditions

HIV Infections

Summary

The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is working with needle exchange programs (syringe service programs) to test whether offering HIV and hepatitis C (HCV) testing to everyone who comes in — rather than waiting for people to ask — increases the number of people who get tested and connected to care. **You may be eligible if...** - You are a syringe service program (SSP) operating in a high-need area designated by the CDC - Your program serves at least 300 unique participants per year - Your program does not currently offer routine opt-out HIV/HCV testing - Key staff are willing to participate in surveys and interviews throughout the study **You may NOT be eligible if...** - Your program currently receives or has previously received specific federal FOCUS funding - You cannot collect and share the required data *Note: This trial enrolls organizations (syringe service programs), not individual patients.* Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALACCESS Intervention

Participants will receive the ACCESS intervention with funding, consisting of up to 16 hours of practice facilitation per month in person and/or virtually. Practice facilitation is training and support on implementation of routine HIV/HCV screening.

BEHAVIORALControl Group

Participants will receive a link to the CDC compendium of evidence-based interventions for HIV prevention.